Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-11-25 Sale |
2024-11-27 5:06 pm |
Contineum Therapeutics Inc. | CTNM | Lorrain Daniel S. Chief Scientific Officer |
1,010 | $16.02 | $16,177 | 172,460 (Indirect Direct) |
View |
| 2024-11-18 Sale |
2024-11-20 5:07 pm |
Contineum Therapeutics Inc. | CTNM | Lorrain Daniel S. Chief Scientific Officer |
6,190 | $16.38 | $101,421 | 173,470 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-01-31 Option Award |
2025-01-31 4:38 pm |
N/A 2035-01-30 |
Contineum Therapeutics Inc. | CTNM | Lorrain Daniel S. Chief Scientific Officer |
113,700 | $0 | 113,700 (Direct) |
View |
| 2024-05-24 Option Award |
2024-05-29 5:58 pm |
N/A 2034-05-23 |
Contineum Therapeutics Inc. | CTNM | Lorrain Daniel S. Chief Scientific Officer |
103,700 | $0 | 103,700 (Direct) |
View |
Ownership |
2024-04-04 5:51 pm |
N/A N/A |
Contineum Therapeutics Inc. | CTNM | Lorrain Daniel S. Chief Scientific Officer |
0 | $0 | 670,865 (Direct) |
View |